NCT06986941Not yet recruiting
The Effects of Ballet-Based Exercise Training on Respiratory Functions, Balance, Cognitive Functions, Peripheral Muscle Strength, Functional Capacity and Quality of Life in Patients With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 23 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study investigates the impact of an 8-week ballet-based dance therapy on people with Parkinson's disease. It aims to assess the effect of ballet on motor and non-motor symptoms, such as balance, cognitive function, functional capacity, and quality of life. The study will provide insights into the potential of ballet therapy as an effective, non-pharmacological treatment for Parkinson's disease.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 4 May 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Bezmialem Vakif University
- Diseases
- Parkinson disease
- NCT number
- NCT06986941
What you commit to
- Study type: Interventional
- Planned participants: 24
- From 1 Jun 2025 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major surgery within the past 6 months.
Other illness
- Mental retardation (severe cognitive impairment).
- Presence of uncontrolled cardiovascular, pulmonary, or oncological diseases.
Other
- Joint deformities or severe movement limitations that prevent participation in dance exercises.
- Diagnosed visual or auditory impairments affecting balance.
Who the study is looking for
- Age 18 years or older.
- Diagnosed with Parkinson's disease.
- Modified Hoehn and Yahr stages I to III.
- Willingness to participate and provide informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.